Skip to main content
. 2013 Jan 15;4(3):187–190. doi: 10.1136/flgastro-2012-100267

Figure 1.

Figure 1

The outcome of the initial assessment of hepatocellular carcinoma (HCC) by a multidisciplinary meeting (MDM) with respect to treatment categorised as resection, liver transplantation, locoregional (L-R) therapies and biological agents or palliation.